These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 3487887)
21. [Cytological screening of precancer and cancer of the cervix uteri]. Novik VI Vopr Onkol; 1990; 36(12):1411-8. PubMed ID: 2288117 [No Abstract] [Full Text] [Related]
22. [On the uniform term determination of the preliminary and minor stages of cervix uteri neoplasms for the area of the German Deocratic Republic]. Philippson U Zentralbl Gynakol; 1968 Aug; 90(32):1073-8. PubMed ID: 5682201 [No Abstract] [Full Text] [Related]
23. Cervical cancer screening data from two cohorts in British Columbia. van Oortmarssen GJ; Habbema JD IARC Sci Publ; 1986; (76):47-60. PubMed ID: 3570415 [No Abstract] [Full Text] [Related]
24. [Cervical cytology prior to demonstration of the cervical cancer]. Vejtorp M; Madsen EM; Bock JE Ugeskr Laeger; 1986 Sep; 148(38):2398-401. PubMed ID: 3765169 [No Abstract] [Full Text] [Related]
25. The Bethesda system and Pap smear screening. Miller K Am Fam Physician; 1995 Feb; 51(2):331-2. PubMed ID: 7840027 [No Abstract] [Full Text] [Related]
26. Management of abnormal cervical smears. Br Med J; 1980 May; 280(6226):1239-40. PubMed ID: 7388485 [No Abstract] [Full Text] [Related]
27. Abnormal cervical cytology. Mendelsohn R; Mann MC Br J Gen Pract; 1992 Dec; 42(365):530-1. PubMed ID: 1297379 [No Abstract] [Full Text] [Related]
29. [Screening for prevention of cervical cancer in the Czech Republic]. Tachezy R; Rob L Cas Lek Cesk; 2007; 146(12):939-44. PubMed ID: 18257411 [TBL] [Abstract][Full Text] [Related]
30. [Experiences and results of cancer prevention examinations in an industrial out-patient clinic]. Wagner S Z Arztl Fortbild (Jena); 1969 Feb; 63(3):155-9. PubMed ID: 5785466 [No Abstract] [Full Text] [Related]
31. [Screening for cervix uteri cancer]. Borràs JM; Iglesias X Med Clin (Barc); 1994; 102 Suppl 1():80-4. PubMed ID: 8170254 [No Abstract] [Full Text] [Related]
32. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996 [TBL] [Abstract][Full Text] [Related]
33. [Preventive screening of the cervix uteri to prevent cervix cancer mortality]. Sindram IS Ned Tijdschr Geneeskd; 1970 May; 114(22):916-21. PubMed ID: 5446493 [No Abstract] [Full Text] [Related]
34. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836 [TBL] [Abstract][Full Text] [Related]
35. [Problem of uterine and ovarian cancer mass screening]. Ohmura M; Oda M Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389 [TBL] [Abstract][Full Text] [Related]
36. The prevention of cervical cancer: the place of the cytological smear test. Hudson E Clin Obstet Gynaecol; 1985 Mar; 12(1):33-51. PubMed ID: 3888487 [TBL] [Abstract][Full Text] [Related]
37. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial]. Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766 [No Abstract] [Full Text] [Related]
38. Results from a cervical cancer screening programme in Manitoba, Canada. Choi NW; Nelson NA IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416 [No Abstract] [Full Text] [Related]